NCT03380858

Brief Summary

In colorectal surgery about 30% of postoperative mortality is attributed to anastomotic leak, whit an incidence range between 1.8% and 15.9%. Preventing the anastomotic leak can therefore bring benefits to the patient and the health system. To date we have technologically advanced suturizers and the correct realization (well-vascularized margins, not in tension, etc.) remains crucial to prevent anastomotic dehiscence. Experimental results demonstrate that modified cyanacrylate is a suitable potential "reinforcement" on intestinal anastomoses (manual or linear intra-corporeal). Applied after mechanical anastomosis, it polymerizes in a short time, closing the spaces of the suture line between one point and the other, expressing an adhesive, hemostatic and sealing action on the tissues, also creating an effective antiseptic barrier towards of the most common infectious or pathogenic agents.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
390

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 2, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2017

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 21, 2017

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2019

Completed
Last Updated

January 16, 2018

Status Verified

January 1, 2018

Enrollment Period

1 month

First QC Date

December 15, 2017

Last Update Submit

January 12, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • fistula incidence

    From day of surgery up to 30 postoperative days

Secondary Outcomes (2)

  • anastomitic bleeding

    From day of surgery up to 30 postoperative days

  • infection

    From day of surgery up to 30 postoperative days

Interventions

colectomyDEVICE

colectomy resection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

390 consecutive patients undergoing colorectal resective surgery with intestinal anastomosis

You may qualify if:

  • Informed consent
  • patients undergoing to oncologic colorectal surgery with colorectal anastomosis

You may not qualify if:

  • refuse informed consent
  • patients undergoing to oncologic colorectal surgery without colorectal anastomosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCSS Pascale

Napoli, Italy

RECRUITING

MeSH Terms

Conditions

Colorectal Neoplasms

Interventions

Colectomy

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, ColorectalDigestive System Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

December 15, 2017

First Posted

December 21, 2017

Study Start

November 2, 2017

Primary Completion

December 2, 2017

Study Completion

May 2, 2019

Last Updated

January 16, 2018

Record last verified: 2018-01

Locations